Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

YOU ARE INVITED!

YOU ARE INVITED!

.... to see the biggest rose bouquet you've ever seen!

Drop by our Rose Beauty House and experience blooming beauty as we open our doors, revealing a world of glamour, inspiration, and transformation.

Femoire’s Rose Beauty House​
📅 26th – 29th Sept, 2024​
⏰10am - 10pm ​
📍The Starhill, KL ​

💫 Get ready to embark on a journey of self-discovery and indulgence 💕

Explore a world of beyond beauty and wonder!

Suggested For You

Kick off July with glowing beauty! ✨

Kick off July with glowing beauty! ✨

Discover the secret to radiant, youthful skin with our new product launch, Femoire Day & Night 🌞🌜 Packed with Japan Patented Rose Placenta® Extract 🌹 it's your ultimate defense against skin aging. Unveil your ideal glow now! 💚💫

7月新品重磅来袭!

与 Femoire Day & Night 一起踏上属于你的素颜美力之旅!以日本专利玫瑰花胎素为主成分,Femoire Day & Night 将会是你的养肤好帮手,帮助你对抗皮肤衰老!赶快来尝试吧!

HAPPY MONDAY FOLKS!

HAPPY MONDAY FOLKS!

I believe the first question we ask our friends in the morning would be "Sudah makan?" or "吃了吗?"

Actually, what you choose to eat for breakfast says a lot about who you are. Are you a roti person or a wantan mee person?

Ever wonder what does your breakfast of choice say about you?

Merry Christmas, WellFam! 🎄✨

Merry Christmas, WellFam! 🎄✨

As you enjoy the festive cheer and holiday treats, don’t let your health and wellness take a backseat.

Remember, the best way to celebrate is with balance and care—because health is the greatest gift of all!

Quiz Time!! 😜

Quiz Time!! 😜

I bet you've always heard of collagen, and how it's good for your skin.

But what exactly does it do?

Comment your guesses below!

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

我们最新一期的时事简报将带你深入探讨肝脏健康!本期的资讯内容涵盖了一系列常见的肝脏疾病,探索了预防病毒性肝炎和脂肪肝的方法,以及我们本期的重点产品 - LIVETAL 和 HOMEGA,为你的肝脏健康助力加持!还有,也别错过了试试我们这期的数字排毒挑战,让自己暂时“退出”数字世界,全面地身心放松!🧡✨

点击下方链接查看完整的时事简报,了解更多关于保持肝脏健康的知识吧!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-cn.pdf